Nutrawerx is bringing plant sciences to the forefront by merging the current understanding of the synergy between naturally occurring plant compounds with standardized methods and practices found in the pharmaceutical industry. Our goal is to become an industry leader in botanical sciences for nutraceutical applications by updating the century-old ideas and techniques of ayurvedic and naturopathic medicines using modern advances in science. Our focus is on the limitless therapeutic potential found in the naturally occurring compounds of Cannabis sativa L. (Cannabis). Cannabis contains a whole host of synergistic molecules, such as cannabinoids, terpenes and flavonoids that have substantial therapeutic value.1
Our team specializes in the production of Cannabis based botanical drug substances, mono-cannabinoid active pharmacological ingredients, and cannabinoid based nutritional supplements. Our objective is to bring cannabinoid based therapies “out of the shadows” and into the mainstream by implementing industry standard methods and practices along with strict quality control protocols to produce pharmaceutical-grade, GMP, FDA, and ISO compliant nutritional supplements. Produced from non-psychoactive varieties of Cannabis (hemp), our products allow consumers to reach their health and wellness goals safely while also being legal to consume in all 50 states and most of the world. Our founders feel strongly that cannabinoids are the medicine of the future and strive to further the cannabis knowledge base by offering medicine delivery systems that are consistent, allowing for the strict double blind tests that are needed to elucidate and verify the vast amount of medical claims that are associated with cannabinoid based therapies.
At Nutrawerx, our mission is to provide high quality, low cost, cannabinoid based nutraceutical products to the global community; as well as promote the legitimate therapeutic potential of cannabinoids, starting with cannabidiol (CBD).
1 Izzo, A. et al. 2009. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences. Volume 30, Issue 10, p 515-527.